When treating patients with clear cell renal cell carcinoma, NDUFV3 was found to be an independent predictor of overall survival (Jia et al., 2018), whereas FKBP11 has the potential to be an early marker for hepatocellular carcinoma (Lin et al., 2013). Here, FKBP11 is linked to clear cell renal carcinoma.